Skip to main content
Erschienen in: Clinical Rheumatology 4/2021

12.09.2020 | Original Article

Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language

verfasst von: Samah M Alian, Nagwa A Sherby, Shymaa A Sarhan

Erschienen in: Clinical Rheumatology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background and objectives

Systemic sclerosis (SSc) is a chronic connective tissue disease affecting all quality of life (QoL) parameters. In addition to clinical assessment, QoL measures should be included in patient assessment. There is no Arabic tool specific for assessing QoL in Arabic SSc patients; therefore, this work was designed to translate the SScQoL questionnaire, culturally adapt and check its reliability and validity.

Method

Based on the principle of translation and cross-cultural adaptation in other language, the SScQoL questionnaire was translated into Arabic. Correlation of SScQoL scores for 50 patients with Short Form Health Survey (SF-36) scores has been tested for convergent validity and discriminate validity evaluated by stratifying clinical parameters of patients and disease subtypes. The intraclass correlation coffee (ICC) was used to assess reliability by interviewing patients twice 14 days apart.

Results

Correlations were present between SScQoL scores and physical and mental component scores of SF-36 questionnaire. We found strong negative correlation between the physical component of SF-36 and QoL function, QoL emotion, QoL total scores (r = − 0.654**, r = − 0.512**, r = − 0.540**) and moderate negative correlation present between SF-36 mental component and QoL function, QoL emotion, QoL social, and QoL total (r = − 0.314*, r = − 0.486**, r = − 0.357*, r = − 0.433*). Also, significant association (P < 0.05*) between scores of total QoL and visceral involvements (GIT involvement, pericardial effusion, and LVDD) was evident. The Arabic edition of SScQoL has a Cronbach’s alpha of 0.78.

Conclusion

The translated Arabic version is a valid and reliable tool to assess Egyptian SSc patients’ QoL.
Key Points
The SScQoL questionnaire items have a convergent validity with physical and mental component scores of SF-36, and discriminant validity with visceral involvement.
The Arabic edition of SScQoL is reliable with a Cronbach’s alpha of 0.78.
Literatur
2.
Zurück zum Zitat Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699CrossRef Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699CrossRef
3.
Zurück zum Zitat Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8(1):38CrossRef Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8(1):38CrossRef
4.
Zurück zum Zitat Strickland G, Pauling J, Cavill C, McHugh N (2012) Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQoL-5D and FACIT-F assessment tools. Clin Rheumatol 31(8):1215–1222CrossRef Strickland G, Pauling J, Cavill C, McHugh N (2012) Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQoL-5D and FACIT-F assessment tools. Clin Rheumatol 31(8):1215–1222CrossRef
5.
Zurück zum Zitat Sierakowska M, Sierakowski S, Olesinska M, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M (2017) Systemic Sclerosis Quality of Life Questionnaire (SScQoL) captures the complex problems experienced by patients with scleroderma. In: Arthritis & rheumatology. Wiley, Hoboken Sierakowska M, Sierakowski S, Olesinska M, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M (2017) Systemic Sclerosis Quality of Life Questionnaire (SScQoL) captures the complex problems experienced by patients with scleroderma. In: Arthritis & rheumatology. Wiley, Hoboken
6.
Zurück zum Zitat Reay N (2008) The quality of life in patients with diffuse and limited systemic sclerosis. University of Leeds Reay N (2008) The quality of life in patients with diffuse and limited systemic sclerosis. University of Leeds
7.
Zurück zum Zitat Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747CrossRef Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747CrossRef
8.
Zurück zum Zitat Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed
9.
Zurück zum Zitat LeRoy EC (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
10.
Zurück zum Zitat Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, García-Díaz S, Hesselstrand R, Kendall C, Matucci-Cerinic M, Mueller-Ladner U (2018) Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis 77(7):1032–1038CrossRef Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, García-Díaz S, Hesselstrand R, Kendall C, Matucci-Cerinic M, Mueller-Ladner U (2018) Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis 77(7):1032–1038CrossRef
11.
Zurück zum Zitat Ware JE Jr (2000) SF-36 health survey update. Spine 25(24):3130–3139CrossRef Ware JE Jr (2000) SF-36 health survey update. Spine 25(24):3130–3139CrossRef
12.
Zurück zum Zitat Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef
13.
Zurück zum Zitat Fayers PM, Machin D (2013) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley Fayers PM, Machin D (2013) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley
14.
Zurück zum Zitat Sierakowska M, Doroszkiewicz H, Sierakowska J, Olesinska M, Grabowska-Jodkowska A, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M, Romanowski W, Zon-Giebel A, Jeka S, Ndosi M (2019) Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Qual Life Res 28(12):3347–3354. https://doi.org/10.1007/s11136-019-02284-9CrossRefPubMedPubMedCentral Sierakowska M, Doroszkiewicz H, Sierakowska J, Olesinska M, Grabowska-Jodkowska A, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M, Romanowski W, Zon-Giebel A, Jeka S, Ndosi M (2019) Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Qual Life Res 28(12):3347–3354. https://​doi.​org/​10.​1007/​s11136-019-02284-9CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Häuser W, Zimmer C, Schiedermaier P, Grandt D (2004) Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 66(6):954–958CrossRef Häuser W, Zimmer C, Schiedermaier P, Grandt D (2004) Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 66(6):954–958CrossRef
16.
Zurück zum Zitat Sierakowska M, Sierakowski S, Sierakowska J, Horton M, Ndosi M (2015) Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: a cross-cultural validation study using Rasch analysis. Qual Life Res 24(3):721–733CrossRef Sierakowska M, Sierakowski S, Sierakowska J, Horton M, Ndosi M (2015) Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: a cross-cultural validation study using Rasch analysis. Qual Life Res 24(3):721–733CrossRef
17.
Zurück zum Zitat Kulikowski K (2014) Quality of life in the context of psychology and medicine. Reumatologia 52(3):200CrossRef Kulikowski K (2014) Quality of life in the context of psychology and medicine. Reumatologia 52(3):200CrossRef
18.
Zurück zum Zitat Cruz-Domínguez MP, Casarrubias-Ramírez M, Gasca-Martínez V, García CM, Carranza-Muleiro RA, Medina G, García-Collinot G, Montes-Cortes DH (2019) The Systemic Sclerosis Questionnaire (SySQ): validation of the translation of the original German version into Spanish and its relationship to the disease and to quality of life. Reumatol Clín (Engl Ed) 15(5):282–288CrossRef Cruz-Domínguez MP, Casarrubias-Ramírez M, Gasca-Martínez V, García CM, Carranza-Muleiro RA, Medina G, García-Collinot G, Montes-Cortes DH (2019) The Systemic Sclerosis Questionnaire (SySQ): validation of the translation of the original German version into Spanish and its relationship to the disease and to quality of life. Reumatol Clín (Engl Ed) 15(5):282–288CrossRef
19.
Zurück zum Zitat Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15(3):268–276CrossRef Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15(3):268–276CrossRef
Metadaten
Titel
Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language
verfasst von
Samah M Alian
Nagwa A Sherby
Shymaa A Sarhan
Publikationsdatum
12.09.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 4/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05373-0

Weitere Artikel der Ausgabe 4/2021

Clinical Rheumatology 4/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.